HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Michelangelo's eye disease.

Abstract
Charged by the Pope Julius II for painting the Cappella Sistina in Rome (between 1508 and 1512), Michelangelo worked in an elevated scaffolding, in an anomalous position with dyes (including poisoning lead salts) and solvents (such as toxic turpentine) dripping on his face and continuously inhaling, in a dim environment illuminated only with oil lamps and candles, as he described himself and sketched in a sonet addressed to Giovanni da Pistoia. In 1510 he began suffering from eye disease: the main symptom was the necessity to elevate the document he was reading up to the level of his eyes. This defect disappeared few months after he finished painting his masterpiece. We hypothesize that the Michelangelo's eyes disease was a form of acquired and transitory nystagmus induced by the many hours he spent in up gaze, with a skew deviation, a form of ocular tilt reaction resulting from the impairment of spatial sensitivity (inversion illusion) due to the persistence of the artist's head in a horizontal position, looking upward.
AuthorsP E Gallenga, Giampiero Neri, Ruggero D'Anastasio, Vito Enrico Pettorrossi, Emilio Alfieri, Luigi Capasso
JournalMedical hypotheses (Med Hypotheses) Vol. 78 Issue 6 Pg. 757-9 (Jun 2012) ISSN: 1532-2777 [Electronic] United States
PMID22425178 (Publication Type: Case Reports, Historical Article, Journal Article)
CopyrightCopyright © 2012 Elsevier Ltd. All rights reserved.
Chemical References
  • Turpentine
Topics
  • Art
  • Darkness
  • History, 16th Century
  • Humans
  • Male
  • Nystagmus, Pathologic (chemically induced, pathology)
  • Paint (toxicity)
  • Turpentine (toxicity)
  • Vatican City

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: